Newsroom

Story

On 18–20 November 2025, the Central African Republic (CAR) celebrated its first-ever Dzanga-Sangha Day (La Journée des Aires Protégées de Dzanga-Sangha). Conceived as a three-day national event, the celebration aimed to shine a spotlight on the country’s unique natural heritage and raise awareness of the Dzanga-Sangha Protected Areas (DSPA)—an extraordinary conservation landscape in CAR’s remote southwest. Held under the theme “Reconciling Nature, Health and Development”, the event underscored how biodiversity protection, community wellbeing, and scientific research intersect in DSPA. It was co-organized by the Government of the Central African Republic in partnership with WWF and the Helmholtz Institute for One Health (HIOH).

03.12.2025

HIOH

[Translate to English:] Rasterelektronenmikroskopische Aufnahme einer Escherichia coli-Zelle (rot), die von Bakteriophagen (grün) infiziert wird.

Story

Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in the first place. But their success has a downside: More and more bacteria are developing strategies to evade the attacks of these drugs. Resistant germs are spreading around the globe, against which hardly any drugs are effective. With the annual World Antimicrobial Resistance Awareness Week (WAAW) from 18 to 24 November, the World Health Organization reminds us how important it is to use antibiotics carefully and how urgently new approaches are needed to continue fighting infections effectively in the future. Almost 20 research groups in the research topic “Novel Anti-Infectives” at the Helmholtz Centre for Infection Research (HZI) are developing new drugs against infectious diseases.

17.11.2025

HZI Campus

HIOH

HIRI

[Translate to English:] Empfangsschild des Arabuko-Sokoke-Nationalparks

Story

Natural substances are an important source of active ingredients used in medicine. However, the chemical diversity of fungi in particular has not yet been sufficiently researched. The EU project Mycobiomics, coordinated by Marc Stadler, Head of the Department “Microbial Drugs” at the Helmholtz Centre for Infection Research (HZI), is investigating the biodiversity of fungi in Europe, Asia and Africa in order to identify pharmaceutically valuable secondary metabolites. In May and June 2025, project participants met in Kenya and South Africa for an expedition and a subsequent symposium.

09.07.2025

HZI Campus

Preparing for historical specimen sampling

Story

From 4 to 6 June 2025, the Department “Pathogen Evolution” led by Prof. Dr. Sébastien Calvignac-Spencer at the Helmholtz Institute for One Health (HIOH) conducted a combined retreat and sampling mission at the Institute of Pathology of the University of Veterinary Medicine Vienna — a key collaboration partner for accessing and studying historical pathological specimens in veterinary medicine. HIOH is a site of the Helmholtz Centre for Infection Research (HZI). The visit focused on collecting around 60 historical tissue samples for molecular genetic analyses related to animal disease research, while also offering time for internal discussions on lab optimization, project development, and team building.

03.07.2025

HIOH

Story

The Republic of Côte d'Ivoire is a vibrant country in West Africa with rich cultural traditions and diverse ecosystems. Despite its beauty and vitality, the country faces significant challenges in its health system, particularly with regard to infectious diseases and antimicrobial resistance (AMR). These challenges are exacerbated by limited healthcare expenditure, which remains among the lowest in the world. Infectious diseases, the risk of zoonotic transmission (i.e., infectious diseases that can spread from animals to humans) and the high burden of healthcare-associated infections pose serious public health problems and make Côte d'Ivoire a priority country for international health cooperation.

03.02.2025

HIOH

Story

Strengthening our microbiome with a pill so that it can effectively fight diseases? HZI researchers are striving to make this vision of the future a reality.

22.11.2024

HZI Campus

HZI in the media

... maßgeblich vorantreiben. In Zusammenarbeit mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung (HZI) und der Utah State ...

16.01.2026

IT Boltwise

... Deutschen Zentrum für Neurodegenerative Erkrankungen, am Helmholtz-Zentrum für Infektionsforschung und am Max-Delbrück-Centrum für ...

16.01.2026

Handelsblatt

Das interdisziplinäre Team aus TWINCORE , Helmholtz Zentrum für Infektionsforschung (HZI) und der Medizinischen Hochschule Hannover ( ...

15.01.2026

Arzt & Wirtschaft

Manche fordern Placebo-kontrollierte Vergleiche von Geimpften und Ungeimpften, um die Sicherheit der Masern-Impfung zu testen. ...

15.01.2026

BR Bayerischer Rundfunk

... können wir Pandemien früh erkennen? Forschende des Helmholtz‑Instituts für One Health zeigen, warum Mensch, ...

13.01.2026

Deutsche Welle

... gewinnbringend eingesetzt werden. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit ...

13.01.2026

juraforum.de

... nach SARS-CoV-2, sagt Fabian Leendertz. Er ist Direktor des Helmholtz-Instituts für One Health (HIOH) in ...

13.01.2026

Deutsche Welle

from the University Hospital Würzburg (UKW), the Helmholtz Institute for RNA-based Infection Research (HIRI), and University of Münster. The

12.01.2026

MSN.com

... des Universitätsklinikums Würzburg (UKW), des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) und der Universität ...

12.01.2026

Biermann Medizin

... potential pandemics early on? Researchers at the Helmholtz Institute for One Health are showing why ...

12.01.2026

Deutsche Welle

Entdeckung

Forschende am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

09.01.2026

Bionity.COM

tools.” – Dr. Anya Sharma, Virologist at the Helmholtz Centre for Infection Research.

Looking Ahead: The Long-Term Implications of

08.01.2026

ARCHYDE

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.